The FDA will approve thalidomide

    The FDA will approve thalidomide.

    Thalidomide was a birth-defect disaster in Europe in the early 1960s. It was originally marketed there as a researchers have discovered that it's a powerful immune suppressant.

    It will initially be approved to treat leprosy complications.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote